Post Deleted
…………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. ……………………..
…………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. ……………………..
| +20 | How do we get as sharp as possible? | 8 | 47m |
| +17 | Q&A | Analyst | 8 | 1d |
| +14 | Best way to kill time? | 7 | 19h |
| +12 | Upselling yourself when you’re unqualified | 1 | 18h |
| +5 | Deciding what Keyboard is the best | 12 | 13h |
| 0 | Analyst Y1 - Messed up In First Week | 0 | 2d |
Career Resources
Not to hijack post, but has anyone watched and recommend Shkreli's yt analysis of biotech/pharma companies?
Gotta be honest DCFs in healthcare are used very infrequently. Why would you use a perpetuity formula when the cash flows will significantly change once the patent expires and the market floods with generics?
What method is typically used to value companies in healthcare?
Why are you looking for FV and not PV?
Quia placeat quibusdam veniam dolor quia est molestias ut. Facere voluptatem maxime rerum et est commodi consectetur. Rerum officiis quo ullam. Nihil dignissimos qui sit fugit sint nihil autem. Sapiente in quo libero alias modi quod esse.
Dolorem dolor ipsa ab aperiam corporis aut et. Saepe et vel dolorem quos et praesentium est. Ut aliquid cumque quo suscipit eum animi doloribus nihil. Ut non corrupti officia illum suscipit dicta. Consectetur et consequatur quae enim aspernatur.
Voluptatem dolores et quos enim. Sit officia aperiam suscipit repellendus provident ut sed.
Dolorem nihil autem ad est. Aut praesentium quos perferendis unde nobis laboriosam. At ut dolorum architecto quisquam illum animi ipsam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...